JMSFF yields 36.90% · PFE yields 6.13%● Live data
📍 JMSFF pulled ahead of the other in Year 1
Combined, JMSFF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JMSFF + PFE for your $10,000?
James Fisher and Sons plc provides marine and specialist engineering services worldwide. It operates through four segments: Marine Support, Specialist Technical, Offshore Oil, and Tankships. The company engages in the provision of ship-to-ship transfer services, aerospace engineering, fabrication, design and engineering hazardous area, marine projects, mechanical and electrical and designs, and specialist engineering and structures consultancy designs; provides inspection and monitoring services, such as condition monitoring, construction plant products, onshore geotechnical, hull stress, load cells, marine and offshore safety systems, non-destructive testing, nuclear plants, offshore wind management, PyroSentry, radiation detection equipment, strain rings, structural, and X-ray inspection systems; and offers lifting and handling services, including container weight systems, crane overload monitoring, hose and umbilical reelers, lifting equipment, load links and shackles, marine cranes, and winches and hoists. It offers marine services, which include digital solutions, fuels infrastructure, installation and commission, offshore personnel and wind management, operation and maintenance, ship agency, shoreside support, site and surface preparation, and vessel chartering services; anchor an chain monitoring, deck and mooring equipment, fendering and flotation, and mooring and towing load monitoring; building infrastructure and services, containerized systems, engineered containments, manipulators and tooling, mechanical and remote handling, radiation tolerant equipment, and remote inspection systems; and subsea equipment and submarine rescue products. In addition, it operates ports in Plymouth, the United Kingdom. James Fisher and Sons Plc was founded in 1847 and is headquartered in Barrow-in-Furness, the United Kingdom.
Full JMSFF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.